Evidence map›Paper›PMID 25378395›Full record

ArticleThe Journal of biological chemistry2014

β2-microglobulin amyloid fibrils are nanoparticles that disrupt lysosomal membrane protein trafficking and inhibit protein degradation by lysosomes.

Toral Jakhria, Andrew L Hellewell, Morwenna Y Porter, Matthew P Jackson, Kevin W Tipping, Wei-Feng Xue, Sheena E Radford, Eric W Hewitt

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Global Proteotoxicity Caused by Human βInternational journal of molecular sciences · 2021
    Article
  4. Review
  5. Misfolded amyloid-β-42 impairs the endosomal-lysosomal pathway.Cellular and molecular life sciences : CMLS · 2020
    Article
  6. Article
  7. A new era for understanding amyloid structures and disease.Nature reviews. Molecular cell biology · 2018
    Review
  8. The structure of a βNature communications · 2018
    Article
  9. Article
  10. Article
  11. Small molecule probes of protein aggregation.Current opinion in chemical biology · 2017
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Toral JakhriaFrom the School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Andrew L HellewellFrom the School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Morwenna Y PorterFrom the School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Matthew P JacksonFrom the School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Kevin W TippingFrom the School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Wei-Feng XueFrom the School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Sheena E RadfordFrom the School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Eric W HewittFrom the School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom e.w.hewitt@leeds.ac.uk.
University of Leeds · GB

Funding

Biotechnology and Biological Sciences Research Council BB/526502/1Biotechnology and Biological Sciences Research Council BB/F01614X/1European Research Council 322408Wellcome Trust 075675Wellcome Trust 092896Wellcome Trust 092896/Z/10/ZWellcome Trust 093794/Z/10/Z
6 · The paper itself

Abstract

Fragmentation of amyloid fibrils produces fibrils that are reduced in length but have an otherwise unchanged molecular architecture. The resultant nanoscale fibril particles inhibit the cellular reduction of the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), a substrate commonly used to measure cell viability, to a greater extent than unfragmented fibrils. Here we show that the internalization of β2-microglobulin (β2m) amyloid fibrils is dependent on fibril length, with fragmented fibrils being more efficiently internalized by cells. Correspondingly, inhibiting the internalization of fragmented β2m fibrils rescued cellular MTT reduction. Incubation of cells with fragmented β2m fibrils did not, however, cause cell death. Instead, fragmented β2m fibrils accumulate in lysosomes, alter the trafficking of lysosomal membrane proteins, and inhibit the degradation of a model protein substrate by lysosomes. These findings suggest that nanoscale fibrils formed early during amyloid assembly reactions or by the fragmentation of longer fibrils could play a role in amyloid disease by disrupting protein degradation by lysosomes and trafficking in the endolysosomal pathway.

Indexed as

ProteolysisAmyloidbeta 2-MicroglobulinCell Line, TumorCell SurvivalHumansIntracellular MembranesLysosomesMembrane ProteinsNanoparticlesOxidation-ReductionPermeabilityProtein TransportAmyloidbeta 2-MicroglobulinMembrane ProteinsAmyloidFibrilLysosomeMembrane TraffickingProtein Degradation

Identifiers

PMID25378395
PMCPMC4276847
OpenAlexW2119596051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.